ConductScience.org, home

Paper6889863

The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.

Daley-Yates PT and 1 other. Biochem Pharmacol, 1982. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid. Papers, record 6889863. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6889863

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.99
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daley-Yates PTP T
2McBrien DCD C

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
FurosemideMajor topic
KidneyMajor topic
ProbenecidMajor topic
Animals
Glomerular Filtration Rate
In Vitro Techniques
Male
Metabolic Clearance Rate
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
32410451A Platinum(IV) Prodrug-Perfluoroaryl Macrocyclic Peptide Conjugate Enhances Platinum Uptake in the Brain.J Med Chem2020https://conductscience.org/library/papers/32410451PubMed
31857146Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling.Toxicol In Vitro2020https://conductscience.org/library/papers/31857146PubMed
27210744Biodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal Failure.Sci Rep2016https://conductscience.org/library/papers/27210744PubMed
24371467Protective Effect of Standardized Extract of Ginkgo biloba against Cisplatin-Induced Nephrotoxicity.Evid Based Complement Alternat Med2013https://conductscience.org/library/papers/24371467PubMed
23917312Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23917312PubMed
22448619Impact of obesity on drug metabolism and elimination in adults and children.Clin Pharmacokinet2012https://conductscience.org/library/papers/22448619PubMed
10554102Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.Pharm Res1999https://conductscience.org/library/papers/10554102PubMed
8261581WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8261581PubMed
7497595A phase I trial of 5-day continuous infusion cisplatin and interferon alpha.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497595PubMed
4053272Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II).Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4053272PubMed
4040567Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.J Pharmacokinet Biopharm1985https://conductscience.org/library/papers/4040567PubMed
3383986Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3383986PubMed
2909288Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2909288PubMed
2729945Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2729945PubMed
1459833Calcium blockers enhance cisplatin-induced nephrotoxicity in rats.Int Urol Nephrol1992https://conductscience.org/library/papers/1459833PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6889863

GET https://conductscience.org/api/papers/v1/6889863/authors